Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy
- PMID: 11280732
Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy
Abstract
Hypoxia inducible factor 1a and 2a (HIF-1a and HIF-2a) are key proteins regulating cellular response to hypoxia. Because the efficacy of photodynamic therapy (PDT) is dependent on the presence of oxygen, the assessment of HIF-1a and HIF-2a expression may be of value in predicting clinical response to PDT. Using recently produced MoAbs, we examined the expression of HIF1a and HIF2a in a series of 37 early-stage esophageal cancers treated with PDT and with additional radiotherapy in case of incomplete response after PDT. Strong expression of the HIF1a and of HIF2a proteins in all optical fields examined was noted in 51% and in 13% of cases, respectively. High expression was associated with a low complete response (CR) rate and with the absence of bcl-2 protein expression. On the contrary, bcl-2 expression was associated with a high CR rate. Combined analysis of HIF1a and bcl-2 protein expression revealed that of 16 cases with high HIF1a expression and the absence of bcl-2 reactivity, only 1 (7%) responded completely to PDT (P = 0.007). Bivariate analysis showed that HIF1a expression was independently related to response to PDT (P = 0.04; t ratio = 2.8), whereas bcl-2 approached significance (P = 0.07; t-ratio = 1.8). The final response to radiotherapy was high (70%) and independent of the HIF and bcl-2 status, which may be a result of reoxygenation after cellular depletion mediated by PDT. The present study suggests that assessment of HIF and of bcl-2 expression are important predictors of in vivo sensitivity to PDT. Modulation of PDT response with bioreductive drugs and/or drugs targeting bcl-2 (i.e., taxanes) may prove of significant therapeutic importance in a subgroup of patients with high HIF expression.
Similar articles
-
Clinical and experimental evidence of Bcl-2 involvement in the response to photodynamic therapy.Anticancer Res. 2001 Jan-Feb;21(1B):663-8. Anticancer Res. 2001. PMID: 11299823
-
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.Br J Cancer. 2001 Sep 14;85(6):881-90. doi: 10.1054/bjoc.2001.2018. Br J Cancer. 2001. PMID: 11556841 Free PMC article.
-
Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.Clin Cancer Res. 2001 May;7(5):1263-72. Clin Cancer Res. 2001. PMID: 11350893
-
Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer.Anticancer Res. 2001 Nov-Dec;21(6B):4317-24. Anticancer Res. 2001. PMID: 11908686 Review.
-
Hypoxia-inducible factor 1 (HIF-1) in cancer.Eur J Surg Oncol. 2004 Jun;30(5):465-8. doi: 10.1016/j.ejso.2004.03.008. Eur J Surg Oncol. 2004. PMID: 15135470 Review.
Cited by
-
HIF-1α -1790G>A polymorphism significantly increases the risk of digestive tract cancer: a meta-analysis.World J Gastroenterol. 2015 Feb 7;21(5):1641-9. doi: 10.3748/wjg.v21.i5.1641. World J Gastroenterol. 2015. PMID: 25663785 Free PMC article. Review.
-
Hypoxia-inducible factor-1alpha polymorphisms and TSC1/2 mutations are complementary in head and neck cancers.Mol Cancer. 2006 Jan 16;5:3. doi: 10.1186/1476-4598-5-3. Mol Cancer. 2006. PMID: 16412252 Free PMC article.
-
Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma.Gynecol Oncol. 2007 Aug;106(2):311-7. doi: 10.1016/j.ygyno.2007.03.041. Epub 2007 May 25. Gynecol Oncol. 2007. PMID: 17532031 Free PMC article.
-
Multifunctional Photoactive Nanomaterials for Photodynamic Therapy against Tumor: Recent Advancements and Perspectives.Pharmaceutics. 2022 Dec 28;15(1):109. doi: 10.3390/pharmaceutics15010109. Pharmaceutics. 2022. PMID: 36678738 Free PMC article. Review.
-
Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma.Gastric Cancer. 2006;9(1):44-9. doi: 10.1007/s10120-005-0356-1. Gastric Cancer. 2006. PMID: 16557436
MeSH terms
Substances
LinkOut - more resources
Medical